ETV5 and neoplasm: Upregulation of ETV5 has been described in endometrial, ovarian and breast cancers, and chondrosarcomas, where it correlates with tumour infiltration and poor prognosis and regulates the expression of genes involved in epithelial-mesenchymal transition (EMT) and invasion25–30.